Dáil Éireann Debate, Tuesday - 30 June 2026
902. Deputy Conor Sheehan asked the Minister for Health if the NCPE is evaluating the application of mounjaro and wegovy for severe metabolic and endocrine conditions alongside obesity; and if she will make a statement on the matter. [49595/26]
Amharc ar fhreagraUnder the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and medical devices. Therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.
